📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
161 analysed today
FollowTelegram
161
Today
149,562
All-time analysed
42,894
Positive
6,654
Negative
91,341
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
33 announcements match the current filters (relevance ≥ 5).
Sudarshan Chemical Allots 9.8 Lakh Equity Shares to Promoter at Rs 1,019.75 per Share
Sudarshan Chemical Industries has completed the allotment of 9,80,000 equity shares to promoter Mr. Rajesh Balkrishna Rathi following the conversion of warrants. The conversion was executed at a price of Rs 1,019.75 per share, bringing in a total capital infusion of approximately Rs 99.93 crore. This transaction has resulted in the promoter group's stake increasing from 8.19% to 9.32%. The company received the final 75% payment of Rs 74.95 crore to facilitate this conversion.
Key Highlights
Allotment of 9,80,000 equity shares of face value Rs 2 each upon warrant conversion.
Conversion price fixed at Rs 1,019.75 per share, including a premium of Rs 1,017.75.
Total capital raised through this warrant exercise amounts to approximately Rs 99.93 crore.
Promoter group holding increased to 9.32% from 8.19% post-allotment.
Paid-up equity share capital increased to Rs 15.92 crore from Rs 15.73 crore.
👀 What to Watch
Investors should view the promoter's decision to increase their stake at a significant premium as a strong sign of confidence in the company's future. Monitor how the newly raised capital is deployed for growth or debt reduction.
Sudarshan Chemical Allots 9.8 Lakh Equity Shares to Promoter at Rs 1,019.75 per Share
Sudarshan Chemical Industries has allotted 9,80,000 equity shares to promoter Mr. Rajesh Balkrishna Rathi following the conversion of warrants. The company received the final 75% payment amounting to Rs 74.95 crore, completing the total consideration of approximately Rs 99.93 crore. This conversion has resulted in the promoter group's stake increasing from 8.19% to 9.32%, while the individual promoter's holding rose from 5.15% to 6.32%.
Key Highlights
Allotment of 9,80,000 equity shares of face value Rs 2 each upon conversion of warrants.
Conversion price set at Rs 1,019.75 per share, including a premium of Rs 1,017.75.
Receipt of Rs 74.95 crore as the remaining 75% consideration for the warrant exercise.
Promoter group holding increased from 8.19% to 9.32% post-allotment.
Total paid-up equity share capital increased from 7,86,27,576 to 7,96,07,576 shares.
👀 What to Watch
Investors should view the promoter's decision to increase their stake at a premium as a sign of long-term confidence in the company's growth prospects.
Sudarshan Chemical Allots 9.8 Lakh Equity Shares to Promoter at Rs 1,019.75 Per Share
Sudarshan Chemical Industries has completed the allotment of 9,80,000 equity shares to promoter Mr. Rajesh Balkrishna Rathi following the conversion of warrants. The conversion was executed at a price of Rs 1,019.75 per share, resulting in a fresh capital infusion of Rs 74.95 crore (the remaining 75% of the total consideration). This transaction increases the total promoter group holding from 8.19% to 9.32%, signaling strong internal confidence in the company's future prospects.
Key Highlights
Allotment of 9,80,000 equity shares of face value Rs 2 each upon conversion of warrants.
Issue price fixed at Rs 1,019.75 per share, including a premium of Rs 1,017.75.
Promoter Mr. Rajesh Balkrishna Rathi's individual stake increased from 5.15% to 6.32%.
Total promoter and promoter group holding rose from 8.19% to 9.32% post-allotment.
Company received the final 75% consideration amounting to Rs 74.95 crore for this conversion.
👀 What to Watch
Investors should take note of the promoter's increased stake and capital infusion as a sign of long-term commitment. The stock may see positive sentiment due to this skin-in-the-game reinforcement.
Sudarshan Chemical Q4 FY26: Net Debt Drops to ₹755 Cr, Acquired Group Beats EBITDA Guidance
Sudarshan Chemical reported a robust Q4 FY26, with the acquired Heubach business delivering a Business EBITDA of €11 million, exceeding its €9-10 million guidance. The company successfully reduced net debt to ₹755 crores from ₹934 crores in the previous quarter, maintaining a healthy debt-to-equity ratio of 0.3x. Integration efforts are progressing with the launch of 'Project Integra' for unified SAP systems and the establishment of a Global Capability Center in India. Management remains confident in achieving a long-term EBITDA target of €90-100 million within 3-4 years.
Key Highlights
Net debt reduced significantly to ₹755 crores in March 2026 from ₹934 crores in December 2025.
Acquired Heubach group delivered €11 million Business EBITDA in Q4, surpassing the projected €9-10 million.
Inventory reduction of €29 million achieved in Q4, exceeding the planned target of €20 million.
RIECO subsidiary returned to profitability with an EBITDA of ₹10 crores on ₹268 crores revenue for FY26.
Management guided for an EBITDA of €35 million for the next financial year despite geopolitical headwinds.
👀 What to Watch
Investors should view the rapid debt reduction and operational turnaround of the acquired Heubach business as strong indicators of successful integration. The stock remains a watch for margin sustainability amidst rising raw material and logistics costs due to the Middle East crisis.
Sudarshan Chemical Q3 FY26: Integration Progresses Amidst Global Demand Headwinds
Sudarshan Chemical reported a challenging Q3 FY26, impacted by weak demand in Europe and North America and significant destocking by customers of the acquired Heubach business. The acquired group saw an EBITDA loss of INR 38 crores, though this was mitigated by INR 40 crores in value capture savings realized during the quarter. Management has initiated a strategic inventory reduction of EUR 30-40 million over the next three quarters to improve cash flow and reduce debt, despite a projected temporary EBITDA hit of EUR 9-12 million. The company maintains a stable net debt-to-equity ratio of 0.5, with a 9-month EPS standing at negative INR 1.4.
Key Highlights
Realized INR 40 crores in value capture savings in Q3 FY26 compared to Q1.
Acquired Heubach business reported an EBITDA loss of INR 38 crores for the quarter.
Strategic plan to reduce inventory by EUR 30-40 million to boost operating cash flow.
Anticipated temporary reduction in reported EBITDA by EUR 9-12 million due to inventory rationalization.
Net debt-to-equity ratio remains healthy at 0.5 despite global macro challenges.
👀 What to Watch
Investors should focus on the company's ability to execute the Heubach integration and monitor the transition from reported EBITDA losses to improved cash flow through inventory reduction. The 'WATCH' status is advised until the temporary margin compression from inventory rationalization stabilizes.
Sudarshan Chemical Q3 PAT at ₹22.5 Cr; Revenue Dips 4.3% YoY to ₹550.3 Cr
Sudarshan Chemical reported a mixed performance for Q3 FY26, with revenue declining 4.3% YoY to ₹550.3 crore. Net profit stood at ₹22.5 crore, which was significantly impacted by a one-time exceptional charge of ₹26.5 crore due to the statutory impact of new Labour Codes on gratuity. On a positive note, the nine-month PAT for FY26 showed strong growth at ₹169.9 crore compared to ₹118.6 crore in the previous year. The company also renewed a €6 million corporate guarantee for its European subsidiary to support working capital needs.
Key Highlights
Revenue from operations fell to ₹550.3 crore in Q3 FY26 from ₹574.8 crore in Q3 FY25.
Net Profit for the quarter was ₹22.5 crore, including a ₹26.5 crore exceptional hit from new Labour Code provisions.
Nine-month PAT increased by 43% YoY to ₹169.9 crore despite a drop in total nine-month revenue to ₹1,664 crore.
Board approved renewal of a €6 million corporate guarantee for wholly-owned subsidiary Sudarshan Europe B.V.
Finance costs decreased to ₹5.7 crore in Q3 FY26 from ₹9.1 crore in the same quarter last year.
👀 What to Watch
Investors should look past the one-time exceptional labor cost hit and focus on the improving nine-month profitability margins. Monitor the successful integration of the Heubach Group acquisition and global pigment demand recovery for long-term growth.
Sudarshan Chemical Q3 FY26: Revenue at ₹2,103 Cr; Heubach Integration Impacts Margins
Sudarshan Chemical reported a consolidated revenue of ₹2,103 Cr for Q3 FY26, largely driven by the acquisition of the Heubach group. While the legacy business contributed ₹712 Cr, the acquired group faced a ₹38 Cr adjusted EBITDA loss due to global demand softness and destocking. Management has revised the FY26 Business EBITDA guidance for the acquired group downward to €16 Mn from €25 Mn. However, the company achieved ₹40 Cr in fixed cost savings during the quarter as part of its integration value capture plan.
Key Highlights
Consolidated Q3 FY26 Revenue reached ₹2,103 Cr, with the Acquired Group contributing ₹1,479 Cr.
One Sudarshan Consolidated Adjusted EBITDA margin stood at 1.9% for Q3, impacted by losses in the acquired entity.
Achieved ₹40 Cr in fixed cost savings in Q3 FY26 through organizational optimization and the new Global Capability Center.
Revised FY26 Business EBITDA outlook for the Acquired Group to ~€16 Mn, down from the previous €25 Mn guidance.
Net Debt stood at ₹1,123 Cr as of December 2025, with a Net Debt to Equity ratio of 0.5.
👀 What to Watch
Investors should closely monitor the integration progress and the realization of the €90-100 Mn EBITDA target by FY29. Short-term volatility is expected as the company rationalizes inventory and navigates low global demand in the coatings and plastics segments.
Sudarshan Chemical Q3 FY26: Revenue at ₹2,103 Cr; Integration Savings of ₹40 Cr Achieved
Sudarshan Chemical reported a consolidated revenue of ₹2,103 Cr for Q3 FY26, down from ₹2,387 Cr in Q2 FY26, reflecting global demand softness and destocking. The company is aggressively integrating its Heubach acquisition, realizing ₹40 Cr in fixed cost savings this quarter, though it revised the Acquired Group's FY26 EBITDA guidance down to €16 Mn. A consolidated PBT loss of ₹123 Cr was recorded, partly due to a ₹46 Cr impact from the New Labour Code. Management remains optimistic about a Q4 recovery and long-term EBITDA targets of €90-100 Mn by FY28/29.
Key Highlights
Consolidated revenue declined to ₹2,103 Cr in Q3 FY26 compared to ₹2,387 Cr in the previous quarter.
Adjusted EBITDA for the combined 'One Sudarshan' entity was ₹25 Cr with a thin margin of 1.5%.
Achieved ₹40 Cr in fixed cost savings during Q3 as part of the post-acquisition value capture plan.
Revised FY26 Business EBITDA guidance for the acquired Heubach assets to €16 Mn from the earlier €25 Mn.
Planning to reduce finished goods inventory by €30-40 Mn over the next three quarters to improve cash flow.
👀 What to Watch
Monitor the progress of the Heubach integration and the company's ability to scale margins back to double digits. The downward revision in near-term guidance suggests a longer turnaround time, making it a 'wait and watch' story for long-term synergy realization.
Sudarshan Chemical Q3 PAT at ₹22.5 Cr; Renews €6 Million Guarantee for European Subsidiary
Sudarshan Chemical reported a standalone Net Profit of ₹22.5 crore for Q3 FY26, a significant drop from ₹74.1 crore in the previous quarter, largely due to a ₹26.5 crore exceptional charge related to new Labour Codes. Revenue from operations for the quarter stood at ₹550.3 crore, compared to ₹582.5 crore in Q2 FY26. The Board also approved the renewal of a €6 million corporate guarantee for its wholly-owned subsidiary, Sudarshan Europe B.V., to secure working capital facilities. This follows the company's major global expansion via the Heubach Group acquisition completed in March 2025.
Key Highlights
Standalone Revenue from operations reached ₹550.3 crore in Q3 FY26, down 5.5% QoQ.
Net Profit impacted by a ₹26.5 crore exceptional item due to statutory changes in Labour Codes (gratuity impact).
Board approved renewal of a €6 million Corporate Guarantee for Sudarshan Europe B.V. for working capital needs.
Nine-month standalone PAT stands at ₹169.9 crore, showing growth over ₹118.6 crore in the previous year's corresponding period.
Company confirmed full utilization of ₹800 crore QIP proceeds for the Heubach Group acquisition and debt repayment.
👀 What to Watch
Investors should monitor the margin recovery in upcoming quarters as the one-time impact of the Labour Code adjustments subsides. The successful integration and performance of the newly acquired Heubach Group assets remain the primary long-term value driver.
Sudarshan Chemical Q3 FY26 PAT at ₹22.5 Cr; Revenue Declines 4% YoY to ₹550.3 Cr
Sudarshan Chemical reported a decline in revenue to ₹550.3 crore for Q3 FY26, down from ₹574.8 crore in the same quarter last year. Net profit for the quarter stood at ₹22.5 crore, which was significantly impacted by a one-time exceptional expense of ₹26.5 crore related to the new Labour Codes. However, the 9-month performance remains strong with PAT at ₹169.9 crore compared to ₹118.6 crore YoY. The company also approved a €6 million corporate guarantee for its European subsidiary to support working capital requirements.
Key Highlights
Revenue from operations decreased 4.3% YoY to ₹550.3 crore in Q3 FY26.
Exceptional item of ₹26.5 crore recognized due to statutory impact of new Labour Codes on gratuity.
9M FY26 PAT grew by 43% YoY to reach ₹169.9 crore.
Finance costs reduced to ₹5.7 crore in Q3 FY26 from ₹9.1 crore in Q3 FY25.
Board approved renewal of €6 million corporate guarantee for wholly owned subsidiary Sudarshan Europe B.V.
👀 What to Watch
Investors should monitor the stabilization of margins following the exceptional labor code impact and the progress of the Heubach Group acquisition integration. The reduction in finance costs suggests improving balance sheet health despite the revenue dip.
Sudarshan Chemical Receives GST Demand Order of Rs 50.58 Crore for FY 2021-22
Sudarshan Chemical Industries Limited has received a GST demand order (DRC-07) from the Deputy Commissioner of State Tax, Maharashtra, for the financial year 2021-22. The total demand amounts to Rs. 50.58 Crores, comprising tax, interest, and penalties. The company has stated that it intends to file an appeal against this order and believes it has a strong case on all points raised. Management currently anticipates no immediate impact on the company's financial or operational activities.
Key Highlights
Total GST demand of Rs. 50,58,05,808 issued for the period April 2021 to March 2022.
The demand includes Tax of Rs. 26.91 Crores, Interest of Rs. 20.98 Crores, and a Penalty of Rs. 2.69 Crores.
Order passed by the Office of Deputy Commissioner of State Tax, Bhosari-513, Maharashtra.
Company is in the process of filing an appeal before the appropriate authority to contest the order.
👀 What to Watch
Investors should monitor the outcome of the appeal process as the demand amount is significant, though the company is confident in its legal position. No immediate change in investment thesis is required pending further legal developments.
Sudarshan Chemical Receives GST Demand Order of ₹50.58 Crores for FY 2021-22
Sudarshan Chemical Industries Limited has received a GST demand order totaling ₹50.58 Crores from the Maharashtra State Tax authorities for the financial year 2021-22. The demand includes a tax component of ₹26.91 Crores, interest of ₹20.98 Crores, and a penalty of ₹2.69 Crores. The company has stated its intention to file an appeal against this order, maintaining that it has a strong case. While management currently expects no immediate impact on operations, the final resolution of this tax dispute remains a key monitorable.
Key Highlights
Total GST demand of ₹50,58,05,808 issued for the period April 2021 to March 2022.
Demand breakdown: ₹26.91 Crores tax, ₹20.98 Crores interest, and ₹2.69 Crores penalty.
Order issued by the Office of Deputy Commissioner of State Tax, Bhosari-513, Maharashtra.
Company is in the process of filing an appeal and believes there is no immediate financial impact.
👀 What to Watch
Investors should monitor the progress of the appeal as the demand amount is significant relative to annual profits. No immediate action is required, but this represents a contingent liability that could impact future cash flows if the appeal is unsuccessful.
Sudarshan Chemical Shareholders Approve Appointment of Four Directors via Postal Ballot
Sudarshan Chemical Industries Limited has successfully passed four resolutions via postal ballot for the appointment of new directors. Shareholders approved the appointment of Apurva Chandra and Rajendra Mariwala as Independent Directors for five-year terms with over 99% support. Additionally, Amitabha Mukhopadhyay and Sanjay K. Asher were appointed as Non-Executive Non-Independent Directors, receiving 93.01% and 95.88% approval respectively. While all resolutions passed with the requisite majority, institutional investors showed some resistance to the non-independent appointments, with up to 17.77% voting against Mr. Mukhopadhyay.
Key Highlights
Apurva Chandra and Rajendra Mariwala appointed as Independent Directors for 5-year terms with over 99% approval.
Amitabha Mukhopadhyay appointed as Non-Executive Director with 93.01% favour; 17.77% of institutional votes were against.
Sanjay K. Asher appointed as Non-Executive Director with 95.88% favour; 10.47% of institutional votes were against.
Total voting turnout was 78.06% of the 78.6 million shares held by 61,236 shareholders on the record date.
👀 What to Watch
Investors should view these appointments as a routine strengthening of the board's governance and oversight. No immediate action is required as the resolutions were passed with comfortable majorities, ensuring management continuity.
